|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 840.72 USD | -0.40% |
|
+3.10% | +2.57% |
| Capitalization | 10TCr 8.98TCr 8.36TCr 7.78TCr 14TCr 9,45300Cr 16TCr 96TCr 38TCr 4,50900Cr 39TCr 38TCr 16,46500Cr | P/E ratio 2026 * |
24.5x | P/E ratio 2027 * | 20.4x |
|---|---|---|---|---|---|
| Enterprise value | 11TCr 9.16TCr 8.53TCr 7.94TCr 15TCr 9,64500Cr 16TCr 98TCr 39TCr 4,60100Cr 40TCr 39TCr 16,80000Cr | EV / Sales 2026 * |
0.26x | EV / Sales 2027 * | 0.23x |
| Free-Float |
44.98% | Yield 2026 * |
0.36% | Yield 2027 * | 0.39% |
More valuation ratios
* Estimated data
More news
Last Transcript: McKesson Corporation
More recommendations
More press releases
More news
| 1 day | -0.40% | ||
| 1 week | +3.10% | ||
| Current month | +2.57% | ||
| 1 month | +3.88% | ||
| 3 months | +8.50% | ||
| 6 months | +17.55% | ||
| Current year | +2.57% |
| 1 week | 815.43 |  | 847.9 |
| 1 month | 794.59 | | 847.9 |
| Current year | 794.59 | | 847.9 |
| 1 year | 570.51 | | 895.58 |
| 3 years | 331.75 | | 895.58 |
| 5 years | 169.34 | | 895.58 |
| 10 years | 106.11 | | 895.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Tyler
CEO | Chief Executive Officer | 59 | 01/04/2019 |
| Director of Finance/CFO | 57 | 01/01/2018 | |
Francisco Fraga
CTO | Chief Tech/Sci/R&D Officer | 53 | 03/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Donald Knauss
CHM | Chairman | 75 | 01/04/2022 |
Bradley Lerman
BRD | Director/Board Member | 70 | 24/04/2018 |
Brian Tyler
BRD | Director/Board Member | 59 | 01/04/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.40% | +3.10% | +41.36% | +119.40% | 10TCr | |
| -0.28% | +6.07% | +67.93% | +179.14% | 5.07TCr | |
| +1.40% | +0.69% | - | - | 2.21TCr | |
| -0.54% | -0.95% | +17.11% | -22.41% | 976.9Cr | |
| -1.03% | -2.69% | -12.81% | -6.31% | 842.24Cr | |
| +0.88% | +0.78% | +2.33% | +1.58% | 818.04Cr | |
| +3.15% | +3.75% | +15.43% | +75.38% | 673.54Cr | |
| -0.51% | -0.15% | +25.78% | +31.33% | 613.25Cr | |
| -2.78% | 0.00% | +7.80% | +3.88% | 386.55Cr | |
| Average | -0.03% | +0.36% | +20.62% | +47.75% | 2.45TCr | |
| Weighted average by Cap. | -0.12% | +2.69% | +41.03% | +111.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 41TCr 35TCr 33TCr 30TCr 57TCr 37,03700Cr 61TCr 3,76800Cr 1,48600Cr 17,66700Cr 1,53100Cr 1,49900Cr 64,50900Cr | 44TCr 38TCr 35TCr 33TCr 62TCr 40,11800Cr 66TCr 4,08200Cr 1,61000Cr 19,13600Cr 1,65800Cr 1,62400Cr 69,87600Cr |
| Net income | 443.06Cr 381.96Cr 355.58Cr 331.03Cr 616.34Cr 40TCr 663.12Cr 4.09TCr 1.61TCr 19TCr 1.66TCr 1.63TCr 70TCr | 515.05Cr 444.02Cr 413.35Cr 384.81Cr 716.48Cr 47TCr 770.87Cr 4.75TCr 1.87TCr 22TCr 1.93TCr 1.89TCr 81TCr |
| Net Debt | 211.61Cr 182.43Cr 169.83Cr 158.11Cr 294.38Cr 19TCr 316.72Cr 1.95TCr 770.3Cr 9.16TCr 793.57Cr 777.24Cr 33TCr | -82Cr -71Cr -66Cr -61Cr -114.19Cr -7.45TCr -122.86Cr -757.82Cr -298.81Cr -3.55TCr -307.84Cr -301.51Cr -13TCr |
More financial data
* Estimated data
Employees
44,000
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | 841.15 $ | -0.35% | 3,13,319 |
| 15/26/15 | 844.13 $ | +1.20% | 6,19,691 |
| 14/26/14 | 834.16 $ | +1.24% | 4,92,918 |
| 13/26/13 | 823.98 $ | -0.20% | 4,87,019 |
| 12/26/12 | 825.62 $ | +1.17% | 4,95,561 |
Delayed Quote Nyse, January 17, 2026 at 12:50 am IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
844.13USD
Average target price
942.00USD
Spread / Average Target
+11.59%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MCK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition